Publications by authors named "Pep Coll"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

77,354

Total Likes

3,799

Extended Reach

1,821,599

Social Features

245
R
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.
Alison J Rodger, Valentina Cambiano, Tina Bruun, Pietro Vernazza, Simon Collins, Olaf Degen, Giulio Maria Corbelli, Vicente Estrada, Anna Maria Geretti, Apostolos Beloukas

Lancet· June 2019

Videos about Article: user user

2 21 243 18 305 3

View All Article and Social Media Activity
S
Strategies to Minimize Time From HIV Acquisition to ART Initiation: The Barcelona Early-cART Program.
Lucia Bailón, Yovaninna Alarcón-Soto, Angel Rivero, Pep Coll, Jorge Saz

Open Forum Infect Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achieving the UNAIDS goals by 2030 in people living with HIV: A simulation model to support the prioritization of health care interventions.
Pep Coll, Inma Jarrín, Esteban Martínez, José Manuel Martínez-Sesmero, Raquel Domínguez-Hernández

Enferm Infecc Microbiol Clin (Engl Ed)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Accuracy of Self-Collected Swabs for the Diagnosis of Mpox.
Maria Ubals, Eloy José Tarín-Vicente, Xènia Oller, Adrià Mendoza, Andrea Alemany, Pep Coll

Clin Infect Dis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain.
Clara Suñer, Maria Ubals, Eloy José Tarín-Vicente, Adrià Mendoza, Andrea Alemany, Pep Coll

Lancet Infect Dis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of the daily HIV pre-exposure prophylaxis in men who have sex with men in Barcelona.
Francesc López Seguí, Unai Oyón Lerga, Laura Laguna Marmol, Pep Coll, Angels Andreu

PLoS One· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life cohort experience after implementing HIV pre-exposure prophylaxis for one year in northwest Spain.
Alexandre Pérez-González, Marta Represa, Pep Coll, Carmen Potel, Silvia Rodríguez-Rivero

Front Public Health· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study.
Eloy José Tarín-Vicente, Andrea Alemany, Manuel Agud-Dios, Maria Ubals, Clara Suñer, Pep Coll, Christian Gutiérrez-Collar

Lancet· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preserved central nervous system functioning after use of romidepsin as a latency-reversing agent in an HIV cure strategy.
Jose A Muñoz-Moreno, Sara Carrillo-Molina, Ignacio Martínez-Zalacaín, Cristina Miranda, Christian Manzardo, Pep Coll

AIDS· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of pre-exposure prophylaxis programme in Spain. Feasibility of four different delivery models.
Carlos Iniesta, Pep Coll, María Jesús Barberá, Miguel García Deltoro, Xabier Camino

PLoS One· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of integrase inhibitor-based antiretroviral therapy on brain outcomes according to time since acquisition of HIV-1 infection.
Anna Prats, Ignacio Martínez-Zalacaín, Beatriz Mothe, Eugènia Negredo, Núria Pérez-Álvarez, Pep Coll

Sci Rep· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Effects of Romidepsin on T-Cell Activation, Apoptosis and Function in the BCN02 HIV-1 Kick&Kill Clinical Trial.
Miriam Rosás-Umbert, Marta Ruiz-Riol, Marco A Fernández, Marta Marszalek, Pep Coll

Front Immunol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02).
Beatriz Mothe, Miriam Rosás-Umbert, Pep Coll, Christian Manzardo, Maria C Puertas

Front Immunol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.
Kenneth H Mayer, Jean-Michel Molina, Melanie A Thompson, Peter L Anderson, Karam C Mounzer, Sean E Collins, Pep Coll

Lancet· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation models and access to HIV pre-exposure prophylaxis in Spain.
Joan Francesc Mir, Manuel F Mazarío, Pep Coll

Enferm Infecc Microbiol Clin (Engl Ed)· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-exposure prophylaxis for HIV: A powerful preventive tool still underused.
Pep Coll

Med Clin (Barc)· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'Therapeutic vaccination refocuses T-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study)' EClinicalMedicine 11 (2019) 65-80.
Beatriz Mothe, Christian Manzardo, Alvaro Sanchez-Bernabeu, Pep Coll, Sara Morón-López

EClinicalMedicine· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study).
Beatriz Mothe, Christian Manzardo, Alvaro Sanchez-Bernabeu, Pep Coll, Sara Morón-López

EClinicalMedicine· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Awareness, knowledge, use, willingness to use and need of Pre-Exposure Prophylaxis (PrEP) during World Gay Pride 2017.
Carlos Iniesta, Débora Álvarez-Del Arco, Luis Miguel García-Sousa, Belén Alejos, Asunción Díaz, Pep Coll

PLoS One· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Awareness, knowledge, use, willingness to use and need of Pre-Exposure Prophylaxis (PrEP) during World Gay Pride 2017.
Carlos Iniesta, Débora Álvarez-Del Arco, Luis Miguel García-Sousa, Belén Alejos, Asunción Díaz, Pep Coll

PLoS One· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Executive summary: Pre-exposure prophylaxis for prevention of HIV infection in adults in Spain: July 2016.
Santiago Moreno, Antonio Antela, Felipe García, Julia Del Amo, Vicente Boix, Pep Coll

Enferm Infecc Microbiol Clin· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of a novel multiplex real-time PCR assay for the diagnosis of sexually-transmitted infections.
Gema Fernández, Elisa Martró, Victoria González, Verónica Saludes, Elisabet Bascuñana, Pep Coll

Enferm Infecc Microbiol Clin· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis